盛新鋰能(002240.SZ)和盛新股權投資以現金向遂寧盛新合計增資2億元
格隆匯 12 月 28日丨盛新鋰能(002240.SZ)公佈,公司全資子公司遂寧盛新鋰業有限公司(“標的公司”或“遂寧盛新”)此次新增註冊資本2億元,由公司和遂寧市盛新股權投資中心(有限合夥)(“盛新股權投資”)以現金出資方式進行增資。
其中公司向其增資人民幣12000萬元,盛新股權投資向其增資人民幣8000萬元,用於標的公司建設投資、購買設備或其他日常生產經營。
此次增資完成後,標的公司的註冊資本由人民幣5000萬元增至人民幣25000萬元,公司持有標的公司的股權比例由100%相應下降至68%,盛新股權投資持有標的公司32%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.